CERS Cerus Corporation
$2.98
Cerus Corporation (CERS) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is a loss of $0.01 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +22.6% since its last earnings release on July 30, 2026.
Cerus Reported Earnings, Narrows Guidance
Thursday, July 30, 2026 · 4:01 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 4:00 PM ET
Earnings Whisper
-
vs ($0.01)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$2.38
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Cerus Corporation
Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Sector
Healthcare
Industry
Biotechnology